Cargando…

Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes

AIMS/HYPOTHESIS: We previously demonstrated that N-glycosylation of plasma proteins and IgGs is different in children with recent-onset type 1 diabetes compared with their healthy siblings. To search for genetic variants contributing to these changes, we undertook a genetic association study of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudman, Najda, Kaur, Simranjeet, Simunović, Vesna, Kifer, Domagoj, Šoić, Dinko, Keser, Toma, Štambuk, Tamara, Klarić, Lucija, Pociot, Flemming, Morahan, Grant, Gornik, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163086/
https://www.ncbi.nlm.nih.gov/pubmed/36907892
http://dx.doi.org/10.1007/s00125-023-05881-z
_version_ 1785037818422099968
author Rudman, Najda
Kaur, Simranjeet
Simunović, Vesna
Kifer, Domagoj
Šoić, Dinko
Keser, Toma
Štambuk, Tamara
Klarić, Lucija
Pociot, Flemming
Morahan, Grant
Gornik, Olga
author_facet Rudman, Najda
Kaur, Simranjeet
Simunović, Vesna
Kifer, Domagoj
Šoić, Dinko
Keser, Toma
Štambuk, Tamara
Klarić, Lucija
Pociot, Flemming
Morahan, Grant
Gornik, Olga
author_sort Rudman, Najda
collection PubMed
description AIMS/HYPOTHESIS: We previously demonstrated that N-glycosylation of plasma proteins and IgGs is different in children with recent-onset type 1 diabetes compared with their healthy siblings. To search for genetic variants contributing to these changes, we undertook a genetic association study of the plasma protein and IgG N-glycome in type 1 diabetes. METHODS: A total of 1105 recent-onset type 1 diabetes patients from the Danish Registry of Childhood and Adolescent Diabetes were genotyped at 183,546 genetic markers, testing these for genetic association with variable levels of 24 IgG and 39 plasma protein N-glycan traits. In the follow-up study, significant associations were validated in 455 samples. RESULTS: This study confirmed previously known plasma protein and/or IgG N-glycosylation loci (candidate genes MGAT3, MGAT5 and ST6GAL1, encoding beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase and ST6 beta-galactoside alpha-2,6-sialyltransferase 1 gene, respectively) and identified novel associations that were not previously reported for the general European population. First, novel genetic associations of IgG-bound glycans were found with SNPs on chromosome 22 residing in two genomic intervals close to candidate gene MGAT3; these include core fucosylated digalactosylated disialylated IgG N-glycan with bisecting N-acetylglucosamine (GlcNAc) (p(discovery)=7.65 × 10(−12), p(replication)=8.33 × 10(−6) for the top associated SNP rs5757680) and core fucosylated digalactosylated glycan with bisecting GlcNAc (p(discovery)=2.88 × 10(−10), p(replication)=3.03 × 10(−3) for the top associated SNP rs137702). The most significant genetic associations of IgG-bound glycans were those with MGAT3. Second, two SNPs in high linkage disequilibrium (missense rs1047286 and synonymous rs2230203) located on chromosome 19 within the protein coding region of the complement C3 gene (C3) showed association with the oligomannose plasma protein N-glycan (p(discovery)=2.43 × 10(−11), p(replication)=8.66 × 10(−4) for the top associated SNP rs1047286). CONCLUSIONS/INTERPRETATION: This study identified novel genetic associations driving the distinct N-glycosylation of plasma proteins and IgGs identified previously at type 1 diabetes onset. Our results highlight the importance of further exploring the potential role of N-glycosylation and its influence on complement activation and type 1 diabetes susceptibility. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-023-05881-z.
format Online
Article
Text
id pubmed-10163086
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-101630862023-05-07 Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes Rudman, Najda Kaur, Simranjeet Simunović, Vesna Kifer, Domagoj Šoić, Dinko Keser, Toma Štambuk, Tamara Klarić, Lucija Pociot, Flemming Morahan, Grant Gornik, Olga Diabetologia Article AIMS/HYPOTHESIS: We previously demonstrated that N-glycosylation of plasma proteins and IgGs is different in children with recent-onset type 1 diabetes compared with their healthy siblings. To search for genetic variants contributing to these changes, we undertook a genetic association study of the plasma protein and IgG N-glycome in type 1 diabetes. METHODS: A total of 1105 recent-onset type 1 diabetes patients from the Danish Registry of Childhood and Adolescent Diabetes were genotyped at 183,546 genetic markers, testing these for genetic association with variable levels of 24 IgG and 39 plasma protein N-glycan traits. In the follow-up study, significant associations were validated in 455 samples. RESULTS: This study confirmed previously known plasma protein and/or IgG N-glycosylation loci (candidate genes MGAT3, MGAT5 and ST6GAL1, encoding beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase, alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase and ST6 beta-galactoside alpha-2,6-sialyltransferase 1 gene, respectively) and identified novel associations that were not previously reported for the general European population. First, novel genetic associations of IgG-bound glycans were found with SNPs on chromosome 22 residing in two genomic intervals close to candidate gene MGAT3; these include core fucosylated digalactosylated disialylated IgG N-glycan with bisecting N-acetylglucosamine (GlcNAc) (p(discovery)=7.65 × 10(−12), p(replication)=8.33 × 10(−6) for the top associated SNP rs5757680) and core fucosylated digalactosylated glycan with bisecting GlcNAc (p(discovery)=2.88 × 10(−10), p(replication)=3.03 × 10(−3) for the top associated SNP rs137702). The most significant genetic associations of IgG-bound glycans were those with MGAT3. Second, two SNPs in high linkage disequilibrium (missense rs1047286 and synonymous rs2230203) located on chromosome 19 within the protein coding region of the complement C3 gene (C3) showed association with the oligomannose plasma protein N-glycan (p(discovery)=2.43 × 10(−11), p(replication)=8.66 × 10(−4) for the top associated SNP rs1047286). CONCLUSIONS/INTERPRETATION: This study identified novel genetic associations driving the distinct N-glycosylation of plasma proteins and IgGs identified previously at type 1 diabetes onset. Our results highlight the importance of further exploring the potential role of N-glycosylation and its influence on complement activation and type 1 diabetes susceptibility. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-023-05881-z. Springer Berlin Heidelberg 2023-03-13 2023 /pmc/articles/PMC10163086/ /pubmed/36907892 http://dx.doi.org/10.1007/s00125-023-05881-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Rudman, Najda
Kaur, Simranjeet
Simunović, Vesna
Kifer, Domagoj
Šoić, Dinko
Keser, Toma
Štambuk, Tamara
Klarić, Lucija
Pociot, Flemming
Morahan, Grant
Gornik, Olga
Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes
title Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes
title_full Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes
title_fullStr Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes
title_full_unstemmed Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes
title_short Integrated glycomics and genetics analyses reveal a potential role for N-glycosylation of plasma proteins and IgGs, as well as the complement system, in the development of type 1 diabetes
title_sort integrated glycomics and genetics analyses reveal a potential role for n-glycosylation of plasma proteins and iggs, as well as the complement system, in the development of type 1 diabetes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163086/
https://www.ncbi.nlm.nih.gov/pubmed/36907892
http://dx.doi.org/10.1007/s00125-023-05881-z
work_keys_str_mv AT rudmannajda integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT kaursimranjeet integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT simunovicvesna integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT kiferdomagoj integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT soicdinko integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT kesertoma integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT stambuktamara integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT klariclucija integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT pociotflemming integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT morahangrant integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes
AT gornikolga integratedglycomicsandgeneticsanalysesrevealapotentialrolefornglycosylationofplasmaproteinsandiggsaswellasthecomplementsysteminthedevelopmentoftype1diabetes